1. Heterogenous antibody and T‐cell responses to SARS‐CoV‐2 mRNA vaccines among immunocompromised young people.
- Author
-
Lu, Liangjian, Chan, Chang Yien, Chan‐Ng, Pauline P. L., Than, Mya, Tan, Pamela S. Y., Lim, Lee Kean, Teo, Sharon, Lau, Perry YW, Ng, Kar Hui, Ang, Elizabeth Y., Karthik, Sivaramakrishnan Venkatesh, Aw, Marion M., Tambyah, Paul A., Yap, Hui Kim, and Lee, Bee Wah
- Subjects
- *
YOUNG adults , *COVID-19 vaccines , *IMMUNOGLOBULINS , *T cells , *ANTIBODY formation , *MONONUCLEAR leukocytes - Abstract
In a representative cohort of immunocompromised young people, we observed marked differences in humoral and cellular responses to a standard two-dose mRNA vaccination regime between disease categories. In conclusion, although immunocompromised young people display attenuated humoral and cellular responses to vaccination in general, there are marked differences in vaccine responses between disease subgroups, not completely explained by immunosuppression used. First, given the heterogeneity in vaccine responses, some patient groups who qualify for an additional primary vaccination dose, for example JIA patients, may not benefit significantly, resulting in suboptimal use of vaccines and vaccination capacity. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF